Glaucoma in 68 Markets – Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2032
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Glaucoma Market Report Overview
The glaucoma market size across the 68M was $3.1 billion in 2023. The “Glaucoma in 68 Markets” research report covers the 68 geographical markets and provides an Excel-based forecast model for the market through 2033.
Glaucoma Market Outlook, 2023-2033 ($ Billion)
Buy the Full Report for More Insights on the Glaucoma Market Report Forecast
The Glaucoma market report contains patient-based forecast sales data for the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan) and sales forecast extrapolations for 61 additional geographical markets (61M).
| Market Size (2023) | $3.1 Billion |
| Key Regions | · Africa
· APAC · Europe · LATAM · Middle East · North America |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Glaucoma Market Segmentation by Regions
The key geographical regions encompassing the glaucoma market include Africa, APAC, Europe, LATAM, the Middle East, and North America. In 2023, North America accounted for the highest regional share of the glaucoma market across 68M.
Glaucoma Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights on the Glaucoma Market
Download a Free Report Sample
Segments Covered in the Report
Glaucoma Market Regional Outlook (Value, $ Billion, 2023-2033)
- Africa
- APAC
- Europe
- LATAM
- Middle East
- North America
Scope
This publication is an expanded version of the Excel model containing the patient-based forecast sales for glaucoma, covered in GlobalData’s report “Glaucoma: Seven -Market Drug Forecast and Market Analysis Update”, published in December 2024. In addition to patient based forecast sales data for the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan), this report contains sales forecast extrapolations for an additional 60 geographical markets (60M), totaling 68 markets (68M).
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipelines.
- Develop business strategies by understanding the trends shaping and driving the 7MM glaucoma therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the 7MM glaucoma therapeutics market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Allergan
Alcon
Pfizer
Merck
Santen
Ocular Therapeutix
pH Pharma
Nicox
DWTI
Thea Pharma
Betaliq
Tarsier Pharma
Table of Contents
Table
Figures
Frequently asked questions
-
What was the glaucoma market sales across the 68M in 2023?
The glaucoma market sales across the 68M was $3.1 billion in 2023.
-
Which was the leading region in the glaucoma market in 2023?
In 2023, North America accounted for the highest regional share of the glaucoma market across 68M.
-
Which are the key geographical regions encompassing the glaucoma market?
The key geographical regions encompassing the glaucoma market include Africa, APAC, Europe, LATAM, the Middle East, and North America.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Glaucoma reports

